End-of-day quote
Korea S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
7,550
KRW
|
+3.00%
|
|
+5.59%
|
-1.05%
|
Apr. 26 |
ADBiotech Co., Ltd. announced that it has received KRW 4.5 billion in funding from Kiwoom Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd
|
CI
| Apr. 25 |
ADBiotech Co., Ltd. announced that it expects to receive KRW 4.5 billion in funding from Kiwoom Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd
|
CI
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
4,722,509
|
5,412,214
|
4,972,002
|
3,342,871
|
3,943,557
|
-
|
-
|
Enterprise Value (EV)
1 |
4,722,509
|
5,412,214
|
4,972,002
|
3,342,871
|
3,943,557
|
3,943,557
|
3,943,557
|
P/E ratio
|
7.9
x
|
7.78
x
|
4.8
x
|
5.89
x
|
6.65
x
|
5.57
x
|
5
x
|
Yield
|
2.91%
|
2.12%
|
3.47%
|
4.93%
|
3.49%
|
4.09%
|
3.97%
|
Capitalization / Revenue
|
0.31
x
|
2.19
x
|
1.67
x
|
1.54
x
|
1.79
x
|
1.67
x
|
1.53
x
|
EV / Revenue
|
0.31
x
|
2.19
x
|
1.67
x
|
1.54
x
|
1.79
x
|
1.67
x
|
1.53
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
0.57
x
|
0.66
x
|
0.39
x
|
0.37
x
|
0.4
x
|
0.38
x
|
0.35
x
|
Nbr of stocks (in thousands)
|
689,471
|
645,701
|
639,781
|
606,146
|
600,264
|
-
|
-
|
Reference price
2 |
7,550
|
9,440
|
8,650
|
6,080
|
7,550
|
7,550
|
7,550
|
Announcement Date
|
1/30/20
|
1/28/21
|
1/26/22
|
1/26/23
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
15,456
|
2,474
|
2,977
|
2,176
|
-
|
2,198
|
2,365
|
2,573
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
727.2
|
1,105
|
1,486
|
835.6
|
511
|
858.9
|
1,000
|
1,169
|
Operating Margin
|
4.71%
|
44.66%
|
49.92%
|
38.4%
|
-
|
39.08%
|
42.29%
|
45.45%
|
Earnings before Tax (EBT)
1 |
893
|
1,140
|
-
|
826.3
|
370.1
|
897
|
1,065
|
1,212
|
Net income
1 |
663.7
|
821.8
|
1,153
|
639.5
|
298
|
647.2
|
776.6
|
892.4
|
Net margin
|
4.29%
|
33.23%
|
38.72%
|
29.39%
|
-
|
29.45%
|
32.84%
|
34.69%
|
EPS
2 |
956.0
|
1,213
|
1,803
|
1,033
|
-
|
1,136
|
1,354
|
1,509
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
220.0
|
200.0
|
300.0
|
300.0
|
-
|
263.3
|
309.1
|
300.0
|
Announcement Date
|
1/30/20
|
1/28/21
|
1/26/22
|
1/26/23
|
2/6/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
750.5
|
586.8
|
612.2
|
700.7
|
451.1
|
412
|
639.9
|
488.8
|
523.5
|
553.4
|
552
|
634
|
600.5
|
641
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
397.2
|
234.9
|
284.7
|
321.3
|
149.8
|
79.85
|
281.7
|
156.7
|
173.1
|
205.4
|
185.5
|
246
|
208
|
265
|
Operating Margin
|
52.92%
|
40.03%
|
46.5%
|
45.85%
|
33.2%
|
19.38%
|
44.02%
|
32.05%
|
33.06%
|
37.11%
|
33.61%
|
38.8%
|
34.64%
|
41.34%
|
Earnings before Tax (EBT)
1 |
482.3
|
281.1
|
272.6
|
354.2
|
154
|
45.45
|
294.6
|
172.3
|
64.47
|
218.5
|
181
|
226
|
127
|
283
|
Net income
1 |
340.8
|
177
|
191.8
|
253.7
|
103.6
|
90.43
|
236.7
|
132.5
|
77.45
|
148.5
|
135
|
182.5
|
147.5
|
209
|
Net margin
|
45.41%
|
30.17%
|
31.32%
|
36.21%
|
22.96%
|
21.95%
|
37%
|
27.11%
|
14.79%
|
26.84%
|
24.46%
|
28.79%
|
24.56%
|
32.61%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/11/21
|
1/26/22
|
5/12/22
|
8/9/22
|
11/10/22
|
1/26/23
|
5/11/23
|
8/10/23
|
11/9/23
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
7.57%
|
8.86%
|
11.9%
|
5.83%
|
2.67%
|
5.7%
|
6.53%
|
7.06%
|
ROA (Net income/ Total Assets)
|
0.53%
|
0.62%
|
0.96%
|
0.6%
|
-
|
0.49%
|
0.54%
|
0.61%
|
Assets
1 |
125,639
|
133,371
|
119,800
|
107,435
|
-
|
131,601
|
144,551
|
146,295
|
Book Value Per Share
2 |
13,332
|
14,363
|
21,922
|
16,307
|
-
|
18,933
|
20,097
|
21,523
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
1/30/20
|
1/28/21
|
1/26/22
|
1/26/23
|
2/6/24
|
-
|
-
|
-
|
Last Close Price
7,550
KRW Average target price
9,008
KRW Spread / Average Target +19.32% Consensus |
1st Jan change
|
Capi.
|
---|
| -1.05% | 2.87B | | -9.33% | 34.78B | | -9.61% | 12.87B | | +7.20% | 9.41B | | +5.66% | 8.76B | | -11.37% | 3.5B | | +2.27% | 3.42B | | +1.58% | 2.83B | | -7.64% | 2.25B | | +9.05% | 964M |
Investment Banking
|